NUFIP2

From Wikipedia, the free encyclopedia


Nuclear fragile X mental retardation protein interacting protein 2
Identifiers
Symbol(s) NUFIP2; PIG1; 182-FIP; 82-FIP; FIP-82; KIAA1321; MGC117262
External IDs OMIM: 609356 MGI1915814 HomoloGene10808
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 57532 68564
Ensembl ENSG00000108256 ENSMUSG00000037857
Uniprot Q7Z417 Q5F2E7
Refseq NM_020772 (mRNA)
NP_065823 (protein)
NM_001024205 (mRNA)
NP_001019376 (protein)
Location Chr 17: 24.61 - 24.65 Mb Chr 11: 77.5 - 77.56 Mb
Pubmed search [1] [2]

Nuclear fragile X mental retardation protein interacting protein 2, also known as NUFIP2, is a human gene.[1]


[edit] References

[edit] Further reading

  • Bonaldo MF, Lennon G, Soares MB (1997). "Normalization and subtraction: two approaches to facilitate gene discovery.". Genome Res. 6 (9): 791–806. PMID 8889548. 
  • Nagase T, Kikuno R, Ishikawa KI, et al. (2000). "Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.". DNA Res. 7 (1): 65–73. PMID 10718198. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932. 
  • Bardoni B, Castets M, Huot ME, et al. (2003). "82-FIP, a novel FMRP (fragile X mental retardation protein) interacting protein, shows a cell cycle-dependent intracellular localization.". Hum. Mol. Genet. 12 (14): 1689–98. PMID 12837692. 
  • Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039. 
  • Brill LM, Salomon AR, Ficarro SB, et al. (2004). "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.". Anal. Chem. 76 (10): 2763–72. doi:10.1021/ac035352d. PMID 15144186. 
  • Jin J, Smith FD, Stark C, et al. (2004). "Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.". Curr. Biol. 14 (16): 1436–50. doi:10.1016/j.cub.2004.07.051. PMID 15324660. 
  • Ballif BA, Villén J, Beausoleil SA, et al. (2005). "Phosphoproteomic analysis of the developing mouse brain.". Mol. Cell Proteomics 3 (11): 1093–101. doi:10.1074/mcp.M400085-MCP200. PMID 15345747. 
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334. 
  • Ramos A, Hollingworth D, Adinolfi S, et al. (2006). "The structure of the N-terminal domain of the fragile X mental retardation protein: a platform for protein-protein interaction.". Structure 14 (1): 21–31. doi:10.1016/j.str.2005.09.018. PMID 16407062. 
  • Beausoleil SA, Villén J, Gerber SA, et al. (2006). "A probability-based approach for high-throughput protein phosphorylation analysis and site localization.". Nat. Biotechnol. 24 (10): 1285–92. doi:10.1038/nbt1240. PMID 16964243. 
  • Olsen JV, Blagoev B, Gnad F, et al. (2006). "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.". Cell 127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID 17081983.